Filter Results
:
(707)
Show Results For
-
All HBS Web
(924)
- People (2)
- News (113)
- Research (707)
- Events (9)
- Multimedia (1)
- Faculty Publications (382)
Show Results For
-
All HBS Web
(924)
- People (2)
- News (113)
- Research (707)
- Events (9)
- Multimedia (1)
- Faculty Publications (382)
Sort by
- Article
Health App Policy: International Comparison of Nine Countries' Approaches
By: Anna Essén, Ariel Dora Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens and David W. Bates
An abundant and growing supply of digital health applications (apps) exists in the commercial tech-sector, which can be bewildering for clinicians, patients, and payers. A growing challenge for the health care system is therefore to facilitate the identification of...
View Details
Keywords:
Digital Health;
Apps;
Health Care and Treatment;
Internet and the Web;
Policy;
Global Range;
Applications and Software
Essén, Anna, Ariel Dora Stern, Christoffer Bjerre Haase, Josip Car, Felix Greaves, Dragana Paparova, Steven Vandeput, Rik Wehrens, and David W. Bates. "Health App Policy: International Comparison of Nine Countries' Approaches." npj Digital Medicine 5, no. 31 (2022).
- 26 Jul 2011
- First Look
First Look: July 26
designed an intervention in which senior managers worked with frontline staff to identify and solve safety-related problems over an 18-month period. On average, the 20 randomly selected treatment hospitals identified 17.3 problems per...
View Details
Keywords:
Sean Silverthorne
- August 2017 (Revised July 2018)
- Case
MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work
By: Elie Ofek and Amanda Dai
In June 2014, MannKind Corporation announced that after years of development and billions of dollars in expenses, the FDA had finally approved its drug, Afrezza. MannKind would thus be the only company with an inhalable insulin on the market. As an alternative to...
View Details
Keywords:
Health Care and Treatment;
Product Launch;
Product Positioning;
Marketing Strategy;
Adoption;
Pharmaceutical Industry
Ofek, Elie, and Amanda Dai. "MannKind Corporation: Take a Deep Breath, This Time Afrezza Will Work." Harvard Business School Case 518-031, August 2017. (Revised July 2018.)
- July – August 2011
- Article
Deliberate Learning to Improve Performance in Dynamic Service Settings: Evidence from Hospital Intensive Care Units
By: I. M. Nembhard and A. L. Tucker
Dynamic service settings-characterized by workers who interact with customers to deliver services in a rapidly changing, uncertain, and complex environment (e.g., hospitals)-play an important role in the economy. Organizational learning studies in these settings have...
View Details
Keywords:
Experience and Expertise;
Customer Focus and Relationships;
Learning;
Health Care and Treatment;
Service Delivery;
Performance Improvement;
Quality;
Groups and Teams;
Cooperation;
Health Industry
Nembhard, I. M., and A. L. Tucker. "Deliberate Learning to Improve Performance in Dynamic Service Settings: Evidence from Hospital Intensive Care Units." Organization Science 22, no. 4 (July–August 2011): 907–922.
- 22 Jul 2019
- Book
How to Be a Digital Platform Leader
research, you identified 209 platform failures between 1995 and 2015 and about 45 successful firms for the same period. What are drivers of success? Yoffie: The most important driver of success is network effects. Network effects create...
View Details
Keywords:
by Martha Lagace
- November 2019
- Article
A Review of Bundled Payments in Total Joint Replacement
By: Olivia Manickas-Hill, Kevin J. Bozic and Thomas W. Feeley
The Bundled Payments for Care Improvement (BPCI) initiative, developed by the U.S. Center for Medicare & Medicaid Innovation, aims to reduce health care expenditures while maintaining or improving patient outcomes.
Several published reports evaluating the impact... View Details
Several published reports evaluating the impact... View Details
Manickas-Hill, Olivia, Kevin J. Bozic, and Thomas W. Feeley. "A Review of Bundled Payments in Total Joint Replacement." Journal of Bone and Joint Surgery Reviews 7, no. 11 (November 2019).
- 19 Sep 2016
- Research & Ideas
Why Isn't Business Research More Relevant to Business Practitioners?
treatment in Microsoft Word. (Case in point, see above: “Egocentric Interpretations of Fairness in Asymmetric, Environmental Social Dilemmas: Explaining Harvesting Behavior and the Role of Communication” vs. “The Impossibility of Auditor...
View Details
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
to prove that a new medication’s benefits merit a higher price if cheaper, similar drugs are available. The process rewards companies whose drugs are more novel or help patients more, while forcing manufacturers of equally or less View Details
- 13 Jan 2003
- Research & Ideas
Making Biotech Work as a Business
create safer and more effective treatments and, of course, reap profits—industry executives, like hopeful patients, still restlessly wait for relief. Given its scientific potential, said Pisano, biotech...
View Details
- 28 Nov 2011
- Research & Ideas
Rethinking the Fairness of Organ Transplants
only treatments are maintenance dialysis and kidney transplantation. The former requires visits to a treatment center for at least 12 hours a week, while a transplant—from either a living family member or a...
View Details
- 19 May 2015
- First Look
First Look: May 19
dominance, with income. Given familiar functional form assumptions on utility and the distributions of ability and preferences, a simple statistic for the effect of preference heterogeneity on marginal tax...
View Details
Keywords:
Sean Silverthorne
- 15 Jan 2018
- Research & Ideas
A Better Business Model for Fighting Cancer
therapies has become a reality, as have immunotherapies that induce or suppress a body’s immune response to treat disease. Yet, this relatively swift progress has not been fast enough for millions of other patients who still lack View Details
- 31 Oct 2004
- Research & Ideas
Bypass Marketing: Are Docs Influenced?
drugs? How frequently do physicians prescribe advertised drugs when other drugs or treatments may be equally effective? We surveyed a national probability sample of 643 physicians practicing in a wide variety of specialties. Data were...
View Details
Keywords:
by Manda Salls
- 12 Dec 2017
- First Look
New Research and Ideas, December 12, 2017
demand and the profitability to engage in exports and R&D, thereby relaxing borrowing constraints and enabling more firms to overcome the fixed-cost hurdle for financing R&D. We decompose the effects of RER changes on productivity...
View Details
Keywords:
Sean Silverthorne
- 30 Aug 2016
- First Look
August 30, 2016
variation generated by the experimental treatments, we model sales force performance to identify the effectiveness of various forms of conditional and unconditional compensation. We account for salesperson View Details
Keywords:
Carmen Nobel
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
iPhoto COVID-19 is having a devastating effect on the emotional, psychological, and social well-being (as well as the physical health) of people around the world. Risk factors for addiction, mental illness, and “deaths of despair” are...
View Details
- 23 Oct 2018
- First Look
New Research and Ideas, October 23, 2018
September 2018 Strategy Science Applying Random Coefficient Models to Strategy Research: Identifying and Exploring Firm Heterogeneous Effects By: Alcácer, Juan, Wilbur Chung, Ashton Hawk, and Gonçalo...
View Details
Keywords:
Dina Gerdeman
- 09 Jan 2018
- First Look
First Look at New Research and Ideas, January 9, 2018
separate studies by the type of entrepreneurial behavior considered: entry into entrepreneurship, performance outcomes, and exit from entrepreneurship. This literature shows common results and many points of disagreement, reflective of the View Details
Keywords:
Sean Silverthorne
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
already have products on the market, as does Amgen, where Gordon M. Binder (MBA '62) served as CEO until his retirement last month (he will continue to serve as chairman through December). Amgen's Epogen (a treatment for anemia in kidney...
View Details
- 13 Mar 2007
- First Look
First Look: March 13, 2007
Describes the challenges of using the Balanced Scorecard to implement a triple-bottom-line strategy for delivering excellent economic, environmental, and social performance. The owners and senior executive team of Amanco, a producer of plastic pipe and complete water...
View Details
Keywords:
Martha Lagace